ADARx Pharmaceuticals Prices IPO Of 21.875 Mln Shares Between $15.00 And $17.00/Share

India, Sept. 21 -- ADARx Pharmaceuticals, Inc. revealed Monday that it has priced an initial public offering or IPO, of 21.875 million shares of its common stock between $15.00 and $17.00 per share, according to an amended Form S-1 filing with the U.S. Securities and Exchange Commission.

The San Diego, California-based late-clinical stage biotechnology company has applied to list its common stock to trade on The Nasdaq Global Select Market under the symbol "ADRX." The offering is contingent upon obtaining such approval.

The underwriters have reserved up to 2% of the shares of common stock offered hereby, for sale, at the IPO price, to directors and officers and certain of its employees, business associates, investors and friends and famil...